Multiple Sclerosis Clinical Trial
Official title:
Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)
The study will use a multimodal therapeutic lifestyle intervention consisting of a study diet, stressing more vegetables and fruit, elimination of foods at greatest risk for food allergy, meditation, self massage, progressive exercise and neuromuscular electrical stimulation for rehabilitation of gait and fatigue disability in the setting of secondary and primary progressive multiple sclerosis with gait disability.
Restoration of function is very rare in individuals with MS who have experienced gradual
worsening in the absence of acute MS symptoms (relapses) and partial or complete recovery of
those acute symptoms (remissions).
A recent case report of a patient with secondary progressive MS documented a transition from
scooter dependence to mild gait disability following the initiation of electrotherapy in the
form of neuromuscular electrical stimulation and nutritional interventions aimed increasing
the nutrient density and decreasing the risk of food sensitivity and food allergies. Multiple
studies of neuromuscular electrical stimulation in athletes, cerebral palsy and stroke
patients have demonstrated gains in strength and coordination. Multiple authors have reported
that antioxidants, essential amino acids and micronutrient rich diets are neuroprotective. It
is likely that the combination of the intensive nutrition and the electrotherapy contributed
to the marked gains in improvement. However in the absence of an additional case report the
strength of the association remains unknown.
The intent of this study is to replicate the interventions from the case report as closely as
possible.
Our primary objective is to measure how many and how completely subjects implement 1) the
nutritional interventions, 2) the home exercise program intervention, and 3) the
electrotherapy intervention and if the improve improved nutrition and exercise are associated
with improved function. To assess improvements in function will measure 1) the change in
nutritional status as reported in food frequency surveys, 24 hr dietary recalls, 2) change in
neurocognitive testing and behaviors, 3) change in self-reported function and disability
scales, 4) change in gait and 5) change in medications doses or classes for MS related
symptoms.
Subjects will be followed for three years. After the first year, subjects will not receive
intensive support from the study team. The subjects return at months 18, 24 and 36 to assess
adherence with study interventions, function and quality of life. Nutrition intake is
assessed again at 24 and 36 months.
To assess for safety we will assess safety labs (kidney and liver function tests) and changes
in weight, and self reported side effects questionnaire.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
| Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
| Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
| Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
| Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
| Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
| Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
| Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
| Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
| Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
| Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
| Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
| Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
| Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
| Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
| Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |